Gemcitabine in Patients With Relapsed or Cisplatin-Refractory Testicular Cancer
- 1 February 1999
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 17 (2) , 512
- https://doi.org/10.1200/jco.1999.17.2.512
Abstract
PURPOSE: Despite generally high cure rates in patients with metastatic testicular germ cell tumors, patients with incomplete response to cisplatin-based first-line therapy or with relapsed disease ...Keywords
This publication has 18 references indexed in Scilit:
- Recent strategies for the use of paclitaxel in the treatment of urological malignancies.World Journal of Urology, 1998
- A phase II trial of paclitaxel in refractory germ cell tumorsCancer, 1998
- GemcitabineDrugs, 1997
- Testicular Germ-Cell CancerNew England Journal of Medicine, 1997
- Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancerAnnals of Oncology, 1996
- Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumorsInvestigational New Drugs, 1995
- Treatment of Relapsed Nonseminomatous Germ Cell Tumors with Vinorelbine: A Trial of the Phase 1/11 Study Group of the Association for Medical Oncology of the German Cancer SocietyOncology Research and Treatment, 1993
- Treatment of testicular cancer: a new and improved model.Journal of Clinical Oncology, 1990
- High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: A phase II studyAnnals of Oncology, 1990
- Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.Journal of Clinical Oncology, 1989